They have the patency right till 2032 in the US and have claimed to be the only approved manufacturer of semaglutide globally
It is expected that Dupixent sales will reach 10 billion by 2023
At this level, appetite suppression is typically strong
The true monthly cost is $249, but the advertised price of $179 is one of the most aggressive intro discounts in the lineup, which sets up sticker shock at month two
So it's a really, really complicated issue because the state is thinking about trade-offs, but these drugs also, they're so effective, so it's just a really difficult issue
On the other hand, the potential synergy among supplements with similar objectives (for example, ketones) should be studied, as well as the already evaluated effect of supplementation together with CHO